Colchicine as inhibitor of caspase-1 and GSTO-1 to regulate inflammation-induced pyroptosis in ischemic heart disease: A computational investigation; [Colchicina como inhibidor de la caspasa-1 y GSTO-1 para regular la piroptosis inducida por inflamación en la cardiopatía isquémica: Una investigación computacional]

Open

Budi Satrijo, Mohammad S. Rohman, Aswoco A. Asmoro, Hani Susianti, Diana Lyrawati, Rislan F. Muhammad

2025 Journal of Pharmacy and Pharmacognosy Research Vol. 13 Issue 3 Article Cited by 0 SDG 3SDG 17 Quartile

Abstract

Context: Inflammation-induced pyroptosis amplification contributes to the deterioration of ischemic heart diseases (IHD). Triggered by inflammasome activation, it provokes inflammatory reactions involving proteins such as glutathione transferase omega-1 (GSTO-1), NLRP-3 inflammasome, and caspase-1 (CASP-1), which might be prevented by colchicine. However, the mechanism remains to be explored. Aims: To explore colchicine's potential to inhibit CASP-1, GSTO-1, and NLRP-3 to alleviate pyroptosis by mean computational methods. Methods: Structures of colchicine, CASP-1, GSTO1-1, and NLRP3 were obtained from databases, followed by molecular docking and dynamics simulations to evaluate colchicine's inhibitory potential. NSC697923 and KT53 were used as reference compounds to validate the docking and molecular dynamics analyses. Results: Molecular docking showed that colchicine binds to CASP-1 and GSTO-1 with lower binding energy than their native ligands, indicating strong inhibitory potential. Molecular dynamics simulations further confirmed that colchicine forms stable and robust interactions with CASP-1 and GSTO-1, supporting its effectiveness as an inhibitor. In contrast, colchicine’s interaction with NLRP-3 was less stable, suggesting a lower inhibitory potential. Comparative analysis with NSC697923 and KT53, potent inhibitors of CASP-1 and GSTO-1, respectively, reinforced colchicine’s stable conformation and sufficient hydrogen bonds despite its slightly higher binding affinity, underscoring its sustained interaction with CASP-1 and GSTO-1. Conclusions: Colchicine showed a promising inhibitory potential agent against CASP-1 and GSTO-1, highlighting its potential for regulating inflammation in IHD. The stable binding of colchicine to CASP-1 and GSTO-1 indicated a potential inhibitory mechanism against inflammation-induced pyroptosis in IHD. © 2025 Journal of Pharmacy & Pharmacognosy Research.

Affiliations

Doctoral Program of Medical Science, Universitas Brawijaya, East Java, Malang, Indonesia; Department of Cardiology and Vascular Medicine, Faculty of Medicine, Universitas Brawijaya, Saiful Anwar General Hospital, Malang, Indonesia; Department of Anaesthesiology and Intensive Therapy, Faculty of Medicine, Universitas Brawijaya, Saiful Anwar General Hospital, Malang, Indonesia; Department of Clinical Pathology, Faculty of Medicine, Universitas Brawijaya, Saiful Anwar Hospital, East Java, Malang, Indonesia; Department of Pharmacy, Faculty of Medicine, Universitas Brawijaya, Malang, Indonesia; Department of Biomedical Sciences, Faculty of Medicine, Universitas Brawijaya, Malang, Indonesia

Research at a Glance

Premium content — register to unlock

Research at a Glance

Register to unlock

Topics & SDG Alignment

Premium content — register to unlock

Topics & SDG Alignment

Register to unlock

Collaboration

Premium content — register to unlock

Collaboration

Register to unlock

Author Profile (Selected)

Premium content — register to unlock

Author Profile (Selected)

Register to unlock

References Overview

Premium content — register to unlock

References Overview

Register to unlock

Journal & Source

Premium content — register to unlock

Journal & Source

Register to unlock

Metadata & Integrity

Premium content — register to unlock

Metadata & Integrity

Register to unlock